Enhancing Aurum’s global influence and reputation
Advocating across the global health sector
Restoring
Hope
Restoring Hope, One Youth at a Time: Inside Aurum’s Youth Care Clubs
Across South Africa’s North West province, Aurum’s Youth Care Clubs (YCCs) are creating safe, youth-led spaces that restore confidence, build resilience, and ensure that young people living with HIV can access the care they need without fear, stigma, or judgement.
Aurum USA is a non-profit organization with African roots enabling the mission of The Aurum Institute to create a healthier world for future generations.
African Thought Leadership
Leading local partner in Africa and local policy and science thought leaders
Science and public health integration
Generate evidence for policy and translates policy into practice
Innovation
Continuously drive tangible progress with technological tools
Deliver excellence
Delivering excellence in all grants and programmes
Evidence to Policy.
Policy to Practice
Clinical
Research
- Basic science
- Multi-sites clinical trials (drugs, vaccines, regimens)
- Biorepository
- Clinical laboratory
Implementation
Research
- Epidemology & geomapping
- Real world evidence
- Biorepository
- Multi-site implementation studies
Health System
Strengthening
- Quality improvement
- System improvement
- Health information system
- Market shaping
Health
Implementation
- Major development intervention programmes
- Targeted intervention projects
- Technical assistance
- Infrastructure development
Our Mission
Aurum USA empowers vulnerable and marginalised communities worldwide by advancing education, adolescent development, scientific research, and strong health systems, with a core focus on HIV/AIDS and TB.
Stories of Impact
When youth thrive, the HIV epidemic shifts
Across South Africa’s North West province, Aurum’s Youth Care Clubs (YCCs) are creating safe, youth-led spaces that restore confidence, build
Our Impact.
Leading TBHIVPrevention & Treatment
0
Screened for TB
0
People tested for HIV
0
COVID vaccines administered to date
Over 13 million
Patient courses of
rifapentine - based TB preventive treatments purchased across
78 countries